Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Jan-Dec;23(1):789-795.
doi: 10.1080/14760584.2024.2395534. Epub 2024 Sep 1.

Indirect protection from rotavirus vaccines: a systematic review

Affiliations

Indirect protection from rotavirus vaccines: a systematic review

Tyler Chavers et al. Expert Rev Vaccines. 2024 Jan-Dec.

Abstract

Introduction: Rotavirus vaccines may provide indirect protection by reducing transmission in the population and thus reducing disease burden.

Methods: This systematic review summarizes estimates of indirect protection from rotavirus vaccines and the methods used to obtain these estimates.

Results: We identified 71 studies published between 2009 and 2022 that provided 399 estimates of indirect protection from rotavirus vaccine. Most estimates (73%) evaluated hospitalizations due to rotavirus gastroenteritis as the outcome and unvaccinated children <5 years old as the agegroup (64%), but there was considerable variability in methods to evaluate indirect protection. For hospitalizations due to rotavirus gastroenteritis among unvaccinated children <5 years old, the median incidence rate ratio was 0.60 (IQR: 0.40-0.87, n = 110 estimates), the median relative percent change in percent positivity was 25% (IQR: 13-44%, n = 49 estimates), and the median relative percent change in absolute number of rotavirus positive tests or rotavirus-specific International Classification of Diseases codes was 42% (IQR: 16-66%, n = 40 estimates).

Conclusions: These findings broadly suggest rotavirus vaccines provide some indirect protection. There is a need to standardize measurement of indirect rotavirus vaccine protection, particularly using consistent outcomes and metrics, and stratifying results by standardized age groups and years since vaccine introduction.

Keywords: Herd protection; indirect protection; indirect vaccine protection; rotavirus; vaccine.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Article selection and breakdown of studies published between 2009 and 2022 identified in a systematic review of indirect protection provided by rotavirus vaccines.
Figure 2.
Figure 2.
Distributions of three metrics of indirect protection of rotavirus vaccine: incidence rate ratios of rotavirus hospitalization (N=110), relative percent change in the percent positivity of rotavirus among hospitalizations (N=49), and relative percent change in the absolute number of rotavirus positive tests or ICD codes (N=40) among hospitalized children less than 5 years of age from studies published between 2009 and 2022 identified in a systematic review of indirect protection provided by rotavirus vaccines. IQR=interquartile range
Figure 3.
Figure 3.
Distributions of indirect protection incidence rate ratios of rotavirus hospitalization among unvaccinated children <5 years of age stratified by country-level child mortality strata from studies published between 2009 and 2022 identified in a systematic review of indirect protection provided by rotavirus vaccines. IQR=Interquartile range

References

    1. Burnett E, Parashar UD, Tate JE. Global Impact of Rotavirus Vaccination on Diarrhea Hospitalizations and Deaths Among Children <5 Years Old: 2006–2019. J Infect Dis. 2020. Oct 13;222(10):1731–1739. - PMC - PubMed
    1. Hallowell BD, Chavers T, Parashar U, Tate JE. Global Estimates of Rotavirus Hospitalizations Among Children Below 5 Years in 2019 and Current and Projected Impacts of Rotavirus Vaccination. J Pediatric Infect Dis Soc. 2021. Dec 14. - PMC - PubMed
    1. Vanderweele TJ, Tchetgen Tchetgen EJ, Halloran ME. Components of the indirect effect in vaccine trials: identification of contagion and infectiousness effects. Epidemiology. 2012;23(5):751–761. - PMC - PubMed
    1. Halloran ME, Struchiner CJ, Longini IM Jr. Study designs for evaluating different efficacy and effectiveness aspects of vaccines. Am J Epidemiol. 1997. Nov 15;146(10):789–803. - PubMed
    1. Mangen MJ, van Duynhoven YT, Vennema H, et al. Is it cost-effective to introduce rotavirus vaccination in the Dutch national immunization program? Vaccine. 2010;28(14):2624–35. - PubMed

Publication types

MeSH terms

Substances